These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10547214)

  • 1. Insulin lispro (Lys(B28), Pro(B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group.
    Akram J; De Verga V
    Diabet Med; 1999 Oct; 16(10):861-6. PubMed ID: 10547214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of type 1 diabetes with insulin lispro during Ramadan.
    Kadiri A; Al-Nakhi A; El-Ghazali S; Jabbar A; Al Arouj M; Akram J; Wyatt J; Assem A; Ristic S
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):482-6. PubMed ID: 11547222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan.
    Mattoo V; Milicevic Z; Malone JK; Schwarzenhofer M; Ekangaki A; Levitt LK; Liong LH; Rais N; Tounsi H;
    Diabetes Res Clin Pract; 2003 Feb; 59(2):137-43. PubMed ID: 12560163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?
    Schmauss S; König A; Landgraf R
    Diabet Med; 1998 Mar; 15(3):247-9. PubMed ID: 9545126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan.
    Hajjaji IM; Eshwihdi N; Barrowman N
    Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
    Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
    Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prandial insulin substitution with insulin lispro or insulin lispro mid mixture vs. basal therapy with insulin glargine: a randomized controlled trial in patients with type 2 diabetes beginning insulin therapy.
    Kazda C; Hülstrunk H; Helsberg K; Langer F; Forst T; Hanefeld M
    J Diabetes Complications; 2006; 20(3):145-52. PubMed ID: 16632233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Anderson JH; Brunelle RL; Keohane P; Koivisto VA; Trautmann ME; Vignati L; DiMarchi R
    Arch Intern Med; 1997 Jun; 157(11):1249-55. PubMed ID: 9183237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan.
    Kobeissy A; Zantout MS; Azar ST
    Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan.
    Hui E; Bravis V; Salih S; Hassanein M; Devendra D
    Int J Clin Pract; 2010 Jul; 64(8):1095-9. PubMed ID: 20337752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.
    Malone JK; Woodworth JR; Arora V; Yang H; Campaigne BN; Hallé JP; Yale JF; Grossman LD
    Clin Ther; 2000 Feb; 22(2):222-30. PubMed ID: 10743981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lispro insulin treatment in comparison with regular human insulin in type 2 diabetic patients living in nursing homes.
    Velussi M
    Diabetes Nutr Metab; 2002 Apr; 15(2):96-100. PubMed ID: 12059098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus.
    Tupola S; Komulainen J; Jääskeläinen J; Sipilä I
    Diabet Med; 2001 Aug; 18(8):654-8. PubMed ID: 11553203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan.
    Salti I;
    Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group.
    Bastyr EJ; Stuart CA; Brodows RG; Schwartz S; Graf CJ; Zagar A; Robertson KE
    Diabetes Care; 2000 Sep; 23(9):1236-41. PubMed ID: 10977012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.